MedTrace Logo

Hippocampal Plasticity of Young Adults With Childhood Adversity

NCT02816502 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 73

Last updated 2021-03-25

No results posted yet for this study

Summary

This study investigates the clinical and neural effects of stress management skill building programs for young adults with childhood adversity. The investigators will recruit a total of 60 young adults (21-35 years old) who will be randomized into two different stress management skill building programs, both of which are 8 weeks long. MRI and psychological assessments will be acquired from all subjects before and after the intervention programs in order to investigate changes in clinical symptoms (such as depression, anxiety and stress) and hippocampus structure and function as well as other neural changes.

Conditions

Interventions

BEHAVIORAL

Stress Management Skill Building Program A

Subject will meet with the instructor and other students in the group once a week and complete homework and track amount of practice during the week.

BEHAVIORAL

Stress Management Skill Building Program B

Subject will meet with the instructor and other students in the group once a week and complete homework and track amount of practice during the week.

Sponsors & Collaborators

  • Massachusetts General Hospital

    collaborator OTHER

  • Mclean Hospital

    lead OTHER

Principal Investigators

  • Diane Joss, PhD · Mclean Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-15
Primary Completion
2018-12-01
Completion
2020-07-07

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02816502 on ClinicalTrials.gov